Dr. Socinski on the Evolving Paradigm of Targeted Therapy in Lung Cancer
Mark A. Socinski, MD, discusses the evolving paradigm of targeted therapy in lung cancer.
Dr. Socinski on Challenges Facing Immunotherapy Combinations
Mark A. Socinski, MD, executive medical director of the Florida Hospital Cancer Institute, discusses challenges facing immunotherapy combinations in patients with non–small cell lung cancer (NSCLC).
Dr Phillips on the Treatment Landscape for Patients With MCL
Dr Chari on the Bridging the Gaps in Hematologic Malignancies Meeting
Dr Danilov on Addressing Unmet Needs in Hematologic Malignancies
Dr Saeed on the Use of Pola-R-CHP in Previously Untreated DLBCL
2 Commerce Drive Cranbury, NJ 08512